Why Is Rare Lung Disease-Focused Savara Stock Trading Lower On Tuesday?

Why did Trump order US chip sales halt to China? How did GameStop's Bitcoin purchase affect its stock? Why did Ford recall over one million vehicles? What impact will Trump’s tariffs have on retailers? How is Nvidia's upcoming earnings influenced by tariffs? Why is the new fiber optic cable improving Newark flights? What caused Macy’s to cut 2025 profit forecast? How will the Trump visa policy affect international students? Why is the EU delaying telecom rules overhaul?

Why Is Rare Lung Disease-Focused Savara Stock Trading Lower On Tuesday?

benzinga.com/general/biotech/25/05/45629309/why-is-rare-lung-disease-focused-savara-stock-trading-lower-on-tuesday

Savara Inc. (NASDAQ:SVRA) on Tuesday announced that it received a U.S. Food And Drug Administration (FDA) refusal To File (RTF)) letter regarding the Biologic license application (BLA) for Molbreevi, a therapy for treating patients with autoimmune Pulmonary Alveolar Proteinosis…

This story appeared on benzinga.com, 2025-05-27 19:40:10.